CCG-100602
| CAS No. | 1207113-88-9 | Cat. No. | BCP45205 |
| Name | CCG-100602 | ||
| Synonyms | CCG 100602; CCG100602; | ||
| Formula | C21H17ClF6N2O2 | M. Wt | 478.82 |
| Description | CCG-100602 inhibits RhoA/C-mediated, SRF-driven luciferase expression in PC-3 prostate cancer cells with an IC50 value of 9.8 µM. CCG-100602 specifically blocks the nuclear localization of MRTF-A, thereby inhibiting the fibrogenic transcription factor SRF. | ||
| Pathways | GPCR/G Protein | ||
| Targets | Ras/Rho | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.